MIRM Mirum Pharmaceuticals, Inc.
$98.22▼ -2.38%
Healthcare
Other
After hours
$98.22▲ +0.00%
Sep 11, 7:30 PM ET
Volume 441.1K
Avg Volume (10D) 469.4K
Key Metrics & Fundamentals
Market Cap
$6.38B
P/E Ratio
–
Div Yield
–%
52W Range
63.23 - 130.00
% vs 50 MA
-8.47%
% vs 200 MA
1.64%
RSI-14
43.8
MACD Histogram
+0.5500
Beta (1Y vs SPY)
0.97
Free Cash Flow
-$69.28M
Gross Rev
$176.24M
Gross Profit
$145.90M
EBITDA
-$39.55M
COGS
$30.35M
Operating Exp
$172.00M
Operating Income
-$26.10M
EBIT
-$26.10M
Pretax Income
-$65.54M
Net Income
-$67.23M
EPS (Diluted)
-1.06
Price & Volume History
Loading chart…
Recent News
Mirum Pharmaceuticals Appoints Dr. Rob Myers as Chief Medical Officer
Business Wire · Sep 8, 2026 12:30 PM
Why Is Mirum Pharmaceuticals (MIRM) Up 6.9% Since Last Earnings Report?
Zacks · Sep 4, 2026 3:30 PM
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
Business Wire · Sep 2, 2026 8:01 PM
Liver Cirrhosis Market to Expand Significantly Through 2036, Driven by Emerging Therapies and Increasing Disease Burden | DelveInsight
PR Newswire · Aug 24, 2026 2:31 PM
Mirum Pharmaceuticals Insider Sold Shares Worth $4,000,000, According to a Recent SEC Filing
MT Newswires · Aug 20, 2026 7:54 AM
Why Mirum Pharmaceuticals (MIRM) Is Down 6.4% After Raising 2026 Sales Outlook Amid Wider Losses – And What's Next
Simply Wall St. · Aug 13, 2026 5:12 PM
Mirum Pharmaceuticals (MIRM) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 12, 2026 11:14 PM
Mirum Pharmaceuticals Insider Sold Shares Worth $1,978,402, According to a Recent SEC Filing
MT Newswires · Aug 11, 2026 9:49 PM
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Aug 11, 2026 8:01 PM
Insmed Catapults 34%, Leading A Biotech Rally. But Mirum Takes A Bath.
Investor's Business Daily · Aug 6, 2026 8:12 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See MIRM's money flow as a full page
Social Sentiment
No Reddit posts found for MIRM.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.